diagnosis and risk stratification of plasma cell disorders (pt 1 of 5 - imf ash satellite)
Published 4 years ago • 2.1K plays • Length 28:51Download video MP4
Download video MP3
Similar videos
-
29:18
risk stratification of plasma cell disorders
-
13:14
2020 treatment algorithm for multiple myeloma and conclusions (part 5 of 5 - imf ash 2019 satellite)
-
47:18
diagnosis and risk assessment in multiple myeloma
-
36:29
upfront therapy for the asct-eligible patient: (pt. 3 of 5 - imf ash satellite)
-
5:16
updated risk stratification model for smoldering multiple myeloma
-
1:03:29
imwg conference series ash 2021: making sense of treatment
-
23:47
evolution of upfront therapy for the asct-ineligible patient (pt 2 of 5 - imf ash 2019 satellite)
-
1:03:39
top myeloma research presented at ash 2022
-
2:47:42
accelerating toward curing myeloma: new data, new agents, and evolving treatment paradigm
-
2:29:01
new strategies for multiple myeloma care: next steps for the future
-
43:52
multiple myeloma: diagnosis and risk assessment | dana-farber cancer institute
-
1:23
standards of care for myeloma patients | ash 2020
-
38:15
recent data on transplantation, consolidation, and maintenance after induction therapy
-
44:37
best multiple myeloma therapies for elderly patients
-
4:17
what is msmart? what is risk stratification?
-
4:20
what were the results of the determination trial presented at asco and eha?
-
1:04:27
myeloma 101 diagnosis & treatment
-
4:16
what is the latest from the international myeloma foundation’s black swan research initiative?
-
1:27:09
imwg conference series: ash 2020